Intelligence · Clinical pipeline
Oncology R&D Pipeline
Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.
Quick answer
Oncology: NovaPharmaNews indexes 5,539 oncology clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.
Top sponsors
- First People's Hospital 474 programs
- Chinese Academy of 400 programs
- United Therapeutics Europe 219 programs
- George Institute for 172 programs
- Takeda 163 programs
- HOFFMANN-LA ROCHE 144 programs
- AstraZeneca 143 programs
- MSD Merck Sharp 131 programs
- Regeneron UK 128 programs
- Anaxis Pharma 125 programs
- Telethon Foundation 113 programs
- Novartis India 110 programs
Pipeline programs
-
Selpercatinib
Eli Lilly and Company
Non-Small Cell Lung Cancer
1 trial -
Sevabertinib
Bayer HealthCare AG
Advanced Non-small Cell Lung Cancer
1 trial -
Sigvotatug Vedotin
Pfizer
Non-Small Cell Lung Cancer
1 trial -
Somatostatin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gallbladder Neoplasms
1 trial -
Sonrotoclax
BEONE MEDICINES AUS PTY LTD
Chronic Lymphocytic Leukemia
4 trials -
Sonrotoclax
BEONE MEDICINES AUS PTY LTD
Mantle Cell Lymphoma
1 trial -
Soquelitinib
Corvus Pharmaceuticals
Peripheral T-Cell Lymphoma, Not Otherwise Specified
1 trial -
Sorafenib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatocellular Carcinoma
2 trials -
Sorafenib
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
Sorafenib (Nexavar, BAY43-9006)
Bayer HealthCare AG
Carcinoma
1 trial -
Sorafenib (Nexavar, BAY43-9006)
Bayer HealthCare AG
Carcinoma, Hepatocellular
1 trial -
Standard First-Line Therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Unresectable Colorectal Cancer
1 trial -
Standard of Care
AbbVie
Non-Squamous Non-Small Cell Lung Cancer
1 trial -
Standard of Care
Telix Innovations
Metastatic Prostate Cancer
1 trial -
Standard treatment: Control arm
United Therapeutics Europe Ltd
Cervical Carcinoma
1 trial -
Subcutaneous Tislelizumab
BEONE MEDICINES AUS PTY LTD
Metastatic Gastric Adenocarcinoma
1 trial -
Subxiphoid uniportal VATS
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Mediastinal Neoplasms
1 trial -
Subxiphoid uniportal VATS
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lung Neoplasms
1 trial -
Suprefact Depot 9 for low-volume metastatic castration-sensitive prostate cancer
Disc Medicine
low-volume metastatic castration-sensitive prostate cancer
1 trial -
Surgery and HIPEC with Lobaplatin
Universal Integrated
Colorectal Neoplasms
1 trial -
Surovatamig
AstraZeneca
Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV
1 trial -
Systematic oral health education
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Malignant Tumor of Head and/or Neck
1 trial -
TAK-788
Takeda
Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
1 trial -
TAMOXIFEN for Breast cancer
Shanghai Reinovax Biologics Co.,LTD
Breast cancer
1 trial -
TAP-144-SR(6M)
Takeda
Premenopausal Breast Cancer
1 trial -
TAP-144-SR(6M)
Takeda
Prostate Cancer
1 trial -
TARA-002
Protara Therapeutics
Bladder (Urothelial, Transitional Cell) Cancer
1 trial -
TAS6417-301
Taiho Pharma Netherlands B.V.
Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations
1 trial -
TAXOL for Recurrent or Metastatic HER2 Ne…
Lacuna Pharma Pty Ltd
Recurrent or Metastatic HER2 Negative Breast Cancer
1 trial -
TCM
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non-small Cell Lung Cancer
1 trial -
THIO-104
MAIA Biotechnology
Non-Small Cell Lung Cancer
1 trial -
TPST-1120
Tempest Therapeutics
Hepatocellular Carcinoma (HCC)
1 trial -
TRIO041
Wuhan Createrna Science and Technology Co., Ltd
Intermediate-stage hepatocellular carcinoma with beyond up-to-7 criteria.
1 trial -
Tamoxifen
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer Female
1 trial -
Tamoxifen
Pfizer
Breast Neoplasms
1 trial -
Tamoxifen
International Peace Maternity and Child Health Hospital
Breast Cancer
1 trial -
Tamoxifen Viatris 20 mg tabletter.
The George Institute
Breast Cancer
1 trial -
Tarlatamab
Amgen
Extensive-Stage Small-Cell Lung Cancer
1 trial -
Tarlatamab
Amgen
Small Cell Lung Cancer (SCLC)
1 trial -
Taselisib
Hoffmann-La Roche
Breast Cancer
1 trial -
Tasisulam-sodium
Eli Lilly and Company
Melanoma
1 trial -
Taxane
Hoffmann-La Roche
Gastric Cancer
1 trial -
Taxotere , Epirubicin
Hospital Authority, Hong Kong
Breast Cancer
1 trial -
Tecentriq 1 200 mg concentrate for solution for infusion
Hoffmann-La Roche
Cancer (Future parent protocols may include other cancer that are not included in this section)
1 trial -
Tecentriq 1 200 mg concentrate for solution for infusion
Ningbo Cancer Hospital
High-risk non-muscle invasive bladder cancer (NMIBC) after transurethral resection of the bladder (TURBT) and pathological assessment.
1 trial -
Tecentriq 840 mg concentrate for solution for infusion
Novo Nordisk A/S
Metastatic pancreatic ductal adenocarcinoma (mPDAC)
1 trial -
Tegafur-Gimeracil-Oteracil Potassium
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Stomach Neoplasm
1 trial -
Telisotuzumab Adizutecan
AbbVie
Non-Small Cell Lung Cancer
1 trial
Frequently asked questions
How many oncology pipeline programs are tracked?
5,539 programs match this therapeutic area based on indication text, program name, and registry metadata.
Where does pipeline data come from?
ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.